There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

Fintel reports that on March 13, 2025, Citigroup initiated coverage of Moderna (NasdaqGS:MRNA) with a Neutral recommendation.

Klinger joined the Cambridge, Massachusetts-based pharmaceutical company in 2021, when Moderna's stock was trading at around ...

In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.

A two-story lab building in East Cambridge is proposed for redevelopment at four stories in a process called “contract zoning ...

mRESVIA ®is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 /Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products ...

An ambitious start-up embodies new optimism that artificial intelligence can turbocharge scientific discovery.

and Cambridge. Moderna will rub shoulders there with the likes of the UK Health Security Agency (UKHSA), with which it is working on early vaccine development for future pandemic threats ...

Artificial intelligence-powered scientific discovery startup Lila Sciences is the latest company to emerge from Flagship ...

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.